2019
Native valve endocarditis caused by ErysipelothrixRhusiopathiae: presenting with refractory heart failure and requiring surgical valve replacement—report on a rare zoonosis
Altibi A, Khalid M, Kak V, Patel B. Native valve endocarditis caused by ErysipelothrixRhusiopathiae: presenting with refractory heart failure and requiring surgical valve replacement—report on a rare zoonosis. BMJ Case Reports 2019, 12: e230891. PMID: 31862813, PMCID: PMC6936573, DOI: 10.1136/bcr-2019-230891.Peer-Reviewed Original ResearchConceptsSevere acute aortic regurgitationInitiation of antimicrobial treatmentNative valve endocarditisLack of feverAcute aortic regurgitationRefractory heart failureSurgical valve replacementValve endocarditisAortic regurgitationValve replacementMale patientsCutaneous manifestationsGram-positive bacillusDifferential diagnosisHeart failureClinical dataAntimicrobial treatmentCutaneous lesionsSystemic infectionBacteraemiaMedical managementClinical meritRare zoonosisOccupational exposureClinical setting
2018
Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis
Vuong H, Ho A, Altibi A, Nakazawa T, Katoh R, Kondo T. Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer – A systematic review and meta-analysis. Lung Cancer 2018, 123: 76-82. PMID: 30089599, DOI: 10.1016/j.lungcan.2018.07.006.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerMET exonCell lung cancerAdvanced non-small cell lung cancerLung cancerGenetic eventsOdds ratioPulmonary sarcomatoid carcinomaMeta-analysisConfidence intervalsC-Met inhibitorsRandom-effects modelSarcomatoid carcinomaPrognostic featuresClinicopathological profileDismal survivalTargeted therapyClinicopathological implicationsGenomic alterationsAdvanced ageWeb of ScienceC-MetNon-smokersRare mutationsPatients